Zymeworks ZYME Accounts payable and other current liabilities (Note 11)
Accounts payable and other current liabilities (Note 11) at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's accounts payable and other current liabilities (note 11).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's accounts payable and other current liabilities (note 11)?
- Zymeworks (ZYME) reported accounts payable and other current liabilities (note 11) of $30.23M in Q1 2026.
- How has Zymeworks's accounts payable and other current liabilities (note 11) changed year-over-year?
- Zymeworks's accounts payable and other current liabilities (note 11) decreased by 20.9% year-over-year, from $38.22M to $30.23M.
- What is the long-term trend for Zymeworks's accounts payable and other current liabilities (note 11)?
- Over 4 years (2021 to 2025), Zymeworks's accounts payable and other current liabilities (note 11) has grown at a -12.8% compound annual growth rate (CAGR), from $62.79M to $36.35M.